MedDataX Logo

Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example

NCT ID: NCT01036763

Last Updated: 2014-03-27

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Documentation of successful therapy with tiotropium (Spiriva Respimat; Spiriva (tiotropium 18 mcg capsules)) in COPD patients requiring long-acting bronchodilators: description of the most important outcome parameters according to the physicians assessment to determine the success of therapy. Such data are not yet available.

Also collection of physicians assessments and patients assessments of efficacy and tolerability of Spiriva Respimat, Spiriva (tiotropium 18 mcg capsules).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea

NCT00540163

Chronic Obstructive Pulmonary Disease
COMPLETED

A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00144326

Pulmonary Disease, Chronic Obstructive
COMPLETED PHASE3

Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

NCT00144339

Pulmonary Disease, Chronic Obstructive
COMPLETED PHASE3

Special Survey Long-term Treatment With Tiotropium on COPD

NCT00638183

Pulmonary Disease, Chronic Obstructive
COMPLETED

Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients

NCT00157235

Pulmonary Disease, Chronic Obstructive
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Design:

observational

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Inclusion criteria COPD patients requiring long-acting bronchodilators according to approved Summary of Product Characteristics (SPC) and guidelines

Exclusion criteria Patients cannot be recruited if any of the general or specific contraindications listed in the Patient information leaflet or the Summary of Product Characteristics applies.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role collaborator

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 1

Ahrensburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 2

Amberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 3

Arnstadt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 4

Auerbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 10

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 5

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 6

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 7

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 8

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 9

Augsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 11

Backnang, , Germany

Site Status

Boehringer Ingelheim Investigational Site 12

Bad Doberan, , Germany

Site Status

Boehringer Ingelheim Investigational Site 13

Bad Kissingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 15

Bad Kötzting, , Germany

Site Status

Boehringer Ingelheim Investigational Site 16

Bad Kötzting, , Germany

Site Status

Boehringer Ingelheim Investigational Site 14

Bad Krozingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 17

Bad Lippspringe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 18

Bad Neuenahr-Ahrweiler, , Germany

Site Status

Boehringer Ingelheim Investigational Site 19

Bad Neustadt an der Saale, , Germany

Site Status

Boehringer Ingelheim Investigational Site 20

Bad Reichenhall, , Germany

Site Status

Boehringer Ingelheim Investigational Site 21

Bad Reichenhall, , Germany

Site Status

Boehringer Ingelheim Investigational Site 22

Bad Sachsa, , Germany

Site Status

Boehringer Ingelheim Investigational Site 23

Bad Wörishofen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 24

Baden-Baden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 25

Ballenstedt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 26

Bamberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 27

Bautzen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 28

Beelitz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 29

Bensheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 30

Bergisch Gladbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 31

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 32

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 33

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 34

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 35

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 36

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 37

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 38

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 39

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 40

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 41

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 42

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 43

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 44

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 45

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 46

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 47

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 48

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 49

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 50

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 51

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 52

Berlin, , Germany

Site Status

Boehringer Ingelheim Investigational Site 53

Bernau, , Germany

Site Status

Boehringer Ingelheim Investigational Site 54

Bitterfeld-Wolfen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 55

Bochum, , Germany

Site Status

Boehringer Ingelheim Investigational Site 56

Bochum, , Germany

Site Status

Boehringer Ingelheim Investigational Site 57

Bonn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 58

Bonn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 59

Bonn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 60

Bonn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 61

Bottrop, , Germany

Site Status

Boehringer Ingelheim Investigational Site 62

Braunschweig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 63

Braunschweig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 64

Bremen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 65

Bremen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 66

Bremen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 67

Bremen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 68

Bremerhaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site 69

Bremerhaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site 70

Bruchsal, , Germany

Site Status

Boehringer Ingelheim Investigational Site 71

Buchholz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 72

Castrop-Rauxel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 73

Celle, , Germany

Site Status

Boehringer Ingelheim Investigational Site 74

Celle, , Germany

Site Status

Boehringer Ingelheim Investigational Site 75

Chemnitz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 76

Coburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 77

Coburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 200

Cologne, , Germany

Site Status

Boehringer Ingelheim Investigational Site 201

Cologne, , Germany

Site Status

Boehringer Ingelheim Investigational Site 202

Cologne, , Germany

Site Status

Boehringer Ingelheim Investigational Site 78

Cottbus, , Germany

Site Status

Boehringer Ingelheim Investigational Site 79

Cottbus, , Germany

Site Status

Boehringer Ingelheim Investigational Site 80

Dachau, , Germany

Site Status

Boehringer Ingelheim Investigational Site 81

Darmstadt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 82

Deggendorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 83

Delitzsch, , Germany

Site Status

Boehringer Ingelheim Investigational Site 84

Dessau, , Germany

Site Status

Boehringer Ingelheim Investigational Site 85

Dillingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 86

Dillingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 87

Donaueschingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 88

Dorsten, , Germany

Site Status

Boehringer Ingelheim Investigational Site 89

Dortmund, , Germany

Site Status

Boehringer Ingelheim Investigational Site 90

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 91

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 92

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 93

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 94

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 95

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 96

Dresden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 97

Düren, , Germany

Site Status

Boehringer Ingelheim Investigational Site 98

Düren, , Germany

Site Status

Boehringer Ingelheim Investigational Site 100

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 101

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 102

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 99

Düsseldorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 103

Eichstätt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 104

Emden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 105

Erbach im Odenwald, , Germany

Site Status

Boehringer Ingelheim Investigational Site 106

Erfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 107

Erfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 108

Erfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 109

Erlangen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 110

Eschwege, , Germany

Site Status

Boehringer Ingelheim Investigational Site 111

Esslingen am Neckar, , Germany

Site Status

Boehringer Ingelheim Investigational Site 112

Esslingen am Neckar, , Germany

Site Status

Boehringer Ingelheim Investigational Site 113

Euskirchen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 114

Fellbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 115

Flensburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 116

Forchheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 123

Föhren, , Germany

Site Status

Boehringer Ingelheim Investigational Site 117

Frankenthal, , Germany

Site Status

Boehringer Ingelheim Investigational Site 118

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 119

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 120

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 121

Frankfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 122

Freising, , Germany

Site Status

Boehringer Ingelheim Investigational Site 124

Fürstenfeldbruck, , Germany

Site Status

Boehringer Ingelheim Investigational Site 125

Fürth, , Germany

Site Status

Boehringer Ingelheim Investigational Site 126

Fürth, , Germany

Site Status

Boehringer Ingelheim Investigational Site 127

Ganderkesee, , Germany

Site Status

Boehringer Ingelheim Investigational Site 128

Gauting, , Germany

Site Status

Boehringer Ingelheim Investigational Site 129

Geilenkirchen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 130

Gelsenkirchen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 131

Gelsenkirchen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 132

Gera, , Germany

Site Status

Boehringer Ingelheim Investigational Site 133

Germering, , Germany

Site Status

Boehringer Ingelheim Investigational Site 134

Giessen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 135

Giessen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 140

Göppingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 141

Göttingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 142

Göttingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 143

Göttingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 136

Greiz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 137

Grevesmühlen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 138

Großenhain, , Germany

Site Status

Boehringer Ingelheim Investigational Site 139

Gummersbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 144

Günzburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 145

Gütersloh, , Germany

Site Status

Boehringer Ingelheim Investigational Site 146

Gütersloh, , Germany

Site Status

Boehringer Ingelheim Investigational Site 147

Gütersloh, , Germany

Site Status

Boehringer Ingelheim Investigational Site 148

Hagen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 149

Halberstadt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 150

Halle, , Germany

Site Status

Boehringer Ingelheim Investigational Site 151

Halle, , Germany

Site Status

Boehringer Ingelheim Investigational Site 152

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 153

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 154

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 155

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 156

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 157

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 158

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 159

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 160

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 161

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 162

Hamburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 163

Hamm, , Germany

Site Status

Boehringer Ingelheim Investigational Site 164

Hanover, , Germany

Site Status

Boehringer Ingelheim Investigational Site 165

Hanover, , Germany

Site Status

Boehringer Ingelheim Investigational Site 166

Hanover, , Germany

Site Status

Boehringer Ingelheim Investigational Site 167

Hanover, , Germany

Site Status

Boehringer Ingelheim Investigational Site 168

Hartha, , Germany

Site Status

Boehringer Ingelheim Investigational Site 169

Heidelberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 170

Heidelberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 171

Heidelberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 172

Heidelberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 173

Heilbronn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 174

Heilbronn, , Germany

Site Status

Boehringer Ingelheim Investigational Site 175

Hemmingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 176

Hemmingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 177

Herne, , Germany

Site Status

Boehringer Ingelheim Investigational Site 178

Hettstedt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 179

Hilden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 180

Husum, , Germany

Site Status

Boehringer Ingelheim Investigational Site 181

Itzehoe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 182

Itzehoe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 183

Kaiserslautern, , Germany

Site Status

Boehringer Ingelheim Investigational Site 184

Kaiserslautern, , Germany

Site Status

Boehringer Ingelheim Investigational Site 185

Kamen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 186

Karlsruhe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 187

Karlsruhe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 188

Kempten, , Germany

Site Status

Boehringer Ingelheim Investigational Site 189

Kiel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 190

Kiel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 191

Kiel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 192

Kirchheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 193

Koblenz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 194

Koblenz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 195

Koblenz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 196

Koblenz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 197

Konstanz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 203

Königs Wusterhausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 204

Köthen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 198

Krefeld, , Germany

Site Status

Boehringer Ingelheim Investigational Site 199

Krefeld, , Germany

Site Status

Boehringer Ingelheim Investigational Site 205

Landshut, , Germany

Site Status

Boehringer Ingelheim Investigational Site 206

Langen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 207

Langenfeld, , Germany

Site Status

Boehringer Ingelheim Investigational Site 208

Langenfeld, , Germany

Site Status

Boehringer Ingelheim Investigational Site 209

Leipzig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 210

Leipzig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 211

Leipzig, , Germany

Site Status

Boehringer Ingelheim Investigational Site 212

Leonberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 213

Leverkusen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 214

Leverkusen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 215

Lichtenfels, , Germany

Site Status

Boehringer Ingelheim Investigational Site 216

Limburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 217

Lippstadt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 221

Loerrach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 218

Ludwigshafen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 219

Ludwigshafen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 222

Lüneburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 223

Lüneburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 224

Lützen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 225

Magdeburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 226

Magdeburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 227

Mainz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 228

Mainz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 229

Mannheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 230

Mannheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 231

Marburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 232

Markkleeberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 233

Marktredwitz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 234

Menden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 235

Minden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 236

Minden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 237

Mönchengladbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 238

Mönchengladbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 239

Mönchengladbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 240

Mühlhausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 241

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 242

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 243

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 244

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 245

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 246

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 247

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 248

München, , Germany

Site Status

Boehringer Ingelheim Investigational Site 249

Münster, , Germany

Site Status

Boehringer Ingelheim Investigational Site 250

Münster, , Germany

Site Status

Boehringer Ingelheim Investigational Site 251

Münster, , Germany

Site Status

Boehringer Ingelheim Investigational Site 252

Neu-Ulm, , Germany

Site Status

Boehringer Ingelheim Investigational Site 253

Neumarkt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 254

Neuwied, , Germany

Site Status

Boehringer Ingelheim Investigational Site 255

Niesky, , Germany

Site Status

Boehringer Ingelheim Investigational Site 256

Norderstedt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 257

Norderstedt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 258

Nordhausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 259

Nuremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 260

Nuremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 261

Nuremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 262

Nuremberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 263

Oberursel, , Germany

Site Status

Boehringer Ingelheim Investigational Site 264

Offenburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 265

Olpe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 266

Oranienburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 267

Oschatz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 268

Oschersleben, , Germany

Site Status

Boehringer Ingelheim Investigational Site 269

Osnabrück, , Germany

Site Status

Boehringer Ingelheim Investigational Site 270

Parsberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 271

Peine, , Germany

Site Status

Boehringer Ingelheim Investigational Site 272

Pforzheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 273

Plauen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 274

Plauen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 275

Plauen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 276

Potsdam, , Germany

Site Status

Boehringer Ingelheim Investigational Site 277

Pulheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 278

Rathenow, , Germany

Site Status

Boehringer Ingelheim Investigational Site 279

Ratingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 280

Raubach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 281

Regensburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 282

Remscheid, , Germany

Site Status

Boehringer Ingelheim Investigational Site 283

Remscheid, , Germany

Site Status

Boehringer Ingelheim Investigational Site 284

Rostock, , Germany

Site Status

Boehringer Ingelheim Investigational Site 285

Rostock, , Germany

Site Status

Boehringer Ingelheim Investigational Site 286

Roth, , Germany

Site Status

Boehringer Ingelheim Investigational Site 287

Rottach-Egern, , Germany

Site Status

Boehringer Ingelheim Investigational Site 288

Rüsselsheim am Main, , Germany

Site Status

Boehringer Ingelheim Investigational Site 289

Rüsselsheim am Main, , Germany

Site Status

Boehringer Ingelheim Investigational Site 290

Saalfeld, , Germany

Site Status

Boehringer Ingelheim Investigational Site 291

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site 292

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site 293

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site 294

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site 295

Saarbrücken, , Germany

Site Status

Boehringer Ingelheim Investigational Site 296

Saarlouis, , Germany

Site Status

Boehringer Ingelheim Investigational Site 297

Saarlouis, , Germany

Site Status

Boehringer Ingelheim Investigational Site 314

Saint Ingbert, , Germany

Site Status

Boehringer Ingelheim Investigational Site 298

Salzgitter, , Germany

Site Status

Boehringer Ingelheim Investigational Site 299

Schmallenberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 300

Schmölln, , Germany

Site Status

Boehringer Ingelheim Investigational Site 301

Schmölln, , Germany

Site Status

Boehringer Ingelheim Investigational Site 302

Schwabach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 303

Schwandorf in Bayern, , Germany

Site Status

Boehringer Ingelheim Investigational Site 305

Schwäbisch Gmünd, , Germany

Site Status

Boehringer Ingelheim Investigational Site 304

Schwedt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 306

Sebnitz, , Germany

Site Status

Boehringer Ingelheim Investigational Site 307

Seevetal, , Germany

Site Status

Boehringer Ingelheim Investigational Site 308

Siegen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 309

Simmern, , Germany

Site Status

Boehringer Ingelheim Investigational Site 310

Sinsheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 311

Solingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 312

Sondershausen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 313

Sonneberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 315

Stade, , Germany

Site Status

Boehringer Ingelheim Investigational Site 316

Stadthagen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 317

Starnberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 318

Starnberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 319

Staufen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 320

Steinbach, , Germany

Site Status

Boehringer Ingelheim Investigational Site 321

Steinhagen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 322

Steinhagen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 323

Strausberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 324

Straußfurt, , Germany

Site Status

Boehringer Ingelheim Investigational Site 325

Stuttgart, , Germany

Site Status

Boehringer Ingelheim Investigational Site 326

Stuttgart, , Germany

Site Status

Boehringer Ingelheim Investigational Site 327

Stuttgart, , Germany

Site Status

Boehringer Ingelheim Investigational Site 328

Stuttgart, , Germany

Site Status

Boehringer Ingelheim Investigational Site 329

Teltow, , Germany

Site Status

Boehringer Ingelheim Investigational Site 330

Teterow, , Germany

Site Status

Boehringer Ingelheim Investigational Site 331

Teuchern, , Germany

Site Status

Boehringer Ingelheim Investigational Site 332

Troisdorf, , Germany

Site Status

Boehringer Ingelheim Investigational Site 333

Ulm, , Germany

Site Status

Boehringer Ingelheim Investigational Site 334

Uttenreuth, , Germany

Site Status

Boehringer Ingelheim Investigational Site 335

Waiblingen, , Germany

Site Status

Boehringer Ingelheim Investigational Site 336

Waren, , Germany

Site Status

Boehringer Ingelheim Investigational Site 337

Weilheim, , Germany

Site Status

Boehringer Ingelheim Investigational Site 338

Weyhe, , Germany

Site Status

Boehringer Ingelheim Investigational Site 339

Wiesbaden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 340

Wiesbaden, , Germany

Site Status

Boehringer Ingelheim Investigational Site 341

Wiesloch, , Germany

Site Status

Boehringer Ingelheim Investigational Site 342

Wilhelmshaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site 343

Wilhelmshaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site 344

Wilhelmshaven, , Germany

Site Status

Boehringer Ingelheim Investigational Site 345

Witten, , Germany

Site Status

Boehringer Ingelheim Investigational Site 346

Witten, , Germany

Site Status

Boehringer Ingelheim Investigational Site 347

Witten, , Germany

Site Status

Boehringer Ingelheim Investigational Site 220

Wittenberg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 348

Wolfsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 349

Wolfsburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 350

Würzburg, , Germany

Site Status

Boehringer Ingelheim Investigational Site 351

Zerbst, , Germany

Site Status

Boehringer Ingelheim Investigational Site 352

Zirndorf, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Rau-Berger H, Kroker A, Mitfessel H, Schmidt H, Glaab T Assessment of COPD-therapy with tiotropium by the treating pneumologist. 53rd Cong of the German Respiratory Society, Nuremberg, 29 Mar - 1 Apr 2012 (Poster), (2012)

Reference Type BACKGROUND

Glaab T, Kroker A, Mitfessel H, Schmdit H, Rau-Berger H Evaluation of COPD treatment success by office-based pneumologists using the example of tiotropium. 21st Ann Cong of the European Respiratory Society (ERS), Amsterdam, 24 - 28 Sep 2011 (Poster), (2011)

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

205.455

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice
NCT00624377 COMPLETED
Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172482 COMPLETED
Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.
NCT02172547 COMPLETED
Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
NCT00570544 COMPLETED
Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice
NCT02172495 COMPLETED
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)
NCT00281567 COMPLETED PHASE3
Tiotropium (Spiriva) Rehabilitation Study
NCT00274521 COMPLETED PHASE3
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
NCT00239447 COMPLETED PHASE3
Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)
NCT00239499 COMPLETED PHASE4
Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease
NCT02177318 COMPLETED
Tiotropium 18ug Inhalation Capsule Using a Handihaler® Among Korean COPD Patients
NCT00620516 COMPLETED
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease
NCT01072396 COMPLETED PHASE4
Spiriva® Assessment of FEV1 (SAFE)
NCT00277264 COMPLETED PHASE3
Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation
NCT02172521 COMPLETED
Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines
NCT00615992 COMPLETED
12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)
NCT00144196 COMPLETED PHASE4
SPIRIVA in Ususal Care
NCT00274079 COMPLETED PHASE4
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
NCT00239408 COMPLETED PHASE4
Tiotropium / Respimat One Year Study in COPD.
NCT00387088 COMPLETED PHASE3
Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT05986591 COMPLETED PHASE3
Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)
NCT00662740 TERMINATED PHASE3
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT03118765 COMPLETED PHASE2
Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients
NCT00274508 COMPLETED PHASE3
A Prescription-Event Monitoring (PEM) Study of Tiotropium
NCT02196194 COMPLETED
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02175342 COMPLETED PHASE2